Ocular Therapeutix (OCUL) EBITDA Margin Growth (3y) (2017 - 2026)
Ocular Therapeutix (OCUL) EBITDA Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 828,504.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7,261.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -2,649.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 9,003.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 30,461.00 |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn | -47,389.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -47,389.00 |
| Mar 31, 2026 | -69,686.00 |
| Dec 31, 2025 | -38,893.00 |
| Sep 30, 2025 | -29,229.00 |
| Jun 30, 2025 | -34,020.00 |
| Mar 31, 2025 | -46,224.00 |
| Dec 31, 2024 | -14,943.00 |
| Sep 30, 2024 | -13,751.00 |
| Jun 30, 2024 | -9,248.00 |
| Mar 31, 2024 | 6,151.00 |
| Dec 31, 2023 | 5,971.00 |
| Sep 30, 2023 | 11,095.00 |
| Jun 30, 2023 | 100,438.00 |
| Mar 31, 2023 | 46,819.00 |
| Dec 31, 2022 | 81,107.00 |
| Sep 30, 2022 | 261,174.00 |
| Jun 30, 2022 | 316,056.00 |
| Mar 31, 2022 | 386,030.00 |
| Dec 31, 2021 | 328,252.00 |
| Sep 30, 2021 | 281,441.00 |